Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > RE RE:HEM just filed 2 Reports: SEDI Insider Filings
View:
Post by milstogo on Mar 24, 2021 8:42am

RE RE:HEM just filed 2 Reports: SEDI Insider Filings

Thanks!

Thomas also posted to let us know the reason
... "Just filed my insider report. Sale: Personal taxes."

https://m.ceo.ca/api/sedi?insider=&symbol=HEM&date=&transaction=&amount=&undefined%5Bcompany_symbol%5D=HEM
Comment by Zoomie1999 on Mar 24, 2021 12:54pm
Was it a sale only?  From my read it appears to be an acquisition and sale of equal amount - in open market.  Did not seem to suggest vesting of options that were then sold.  Admittedly, not clear to me.  Thanks everyone!
Comment by milstogo on Mar 24, 2021 2:09pm
Doesn't specify as far as I can see. Thomas just said sale for personal taxes. Nothing about buying. You can always go to the ceo board and see if they can clarify. 
Hemostemix Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities